Literature DB >> 28728272

[The level of asthma control in China from a national asthma control survey].

J T Lin1, W Q Wang, X Zhou, C Z Wang, M Huang, S X Cai, P Chen, Q C Lin, J Y Zhou, Y H Gu, Y D Yuan, D J Sun, X H Yang, L Yang, J M Huo, Z C Chen, P Jiang, J Zhang, X W Ye, H G Liu, H P Tang, R Y Liu, C T Liu, W Zhang, C P Hu, Y Q Chen, X J Liu, L M Dai, W Zhou, Y J Huang, J Y Xu.   

Abstract

Objective: To assess the overall asthma control level in urban China.
Methods: A multi-center, cross-sectional, questionnaire-based survey was carried out in 30 provinces in China (except Tibet). Asthmatic outpatients who met the inclusion criteria were recruited consecutively from 30 sub-centers from October 2015 to May 2016. Data of demographic characteristics, asthma control, asthma management, asthma exacerbations and self-management, and disease perception were collected by face-to-face interviews.
Results: Totally 3 875 asthmatic outpatients were recruited. Asthma control level was assessed according to GINA 2015. The prevalence of asthma control was 28.5%(1 099/3 854). Among 10 cities, which were also involved in the asthma control survey in 2008, the level of asthma control improved from 28.7% in 2008 to 39.2%(533/1 361) in 2016. The rate of hospitalizations due to asthma exacerbations was 26.4%(1 017/3 858) and the rate of emergency visits was 22.4%(864/3 858). Among adult patients, 18.4%(568/3 092) of them had been absent from work while 63.6%(63/99) adolescent patients had been absent from school because of asthma attacks in the previous year.
Conclusion: Although the level of asthma control in China is still far from ideal at present, the status has been improved in some cities. Poorly controlled asthma resulted in increase of hospitalizations, emergency department visits and work/school absences.

Entities:  

Keywords:  Asthma; Asthma control; Cross-sectional studies; Multicenter studies; Questionnaires

Mesh:

Year:  2017        PMID: 28728272     DOI: 10.3760/cma.j.issn.1001-0939.2017.07.002

Source DB:  PubMed          Journal:  Zhonghua Jie He He Hu Xi Za Zhi        ISSN: 1001-0939


  4 in total

1.  Fibroblast growth factor 10 protects against particulate matter-induced airway inflammatory response through regulating inflammatory signaling and apoptosis.

Authors:  Lingjing Liu; Ziqiang Xia; Jingli Li; Yiran Hu; Qiang Wang; Junjie Chen; Shiqian Fan; Jinming Wu; Nian Dong; Chengshui Chen
Journal:  Am J Transl Res       Date:  2019-11-15       Impact factor: 4.060

2.  Translation and validation of the Chinese version of Patient-completed Asthma Knowledge Questionnaire and its implementation in patient education.

Authors:  Bo Peng; Lin Sun; Yan Shang; Yajuan Zhang; Xiwen Gao; Ling Ye; Meiling Jin; Wei He; Zhijun Jie; Chunling Du; Lei Zhou; Yang Liu; Xiaolian Song; Juan Du; Fengying Zhang; Yi Gong; Yuheng Shi; Wuping Bao; Haihua Chen; Jin Wang; Chijun Wen; Weihao Li; Dandan Zhao; Gang Wang; Xin Zhou; Wei Tang
Journal:  J Thorac Dis       Date:  2022-04       Impact factor: 2.895

3.  Asthma Management Using the Mobile Asthma Evaluation and Management System in China.

Authors:  Jiangtao Lin; Wenya Wang; Huaping Tang; Jianmin Huo; Yuhai Gu; Rongyu Liu; Ping Chen; Yadong Yuan; Xiaohong Yang; Jianying Xu; Dejun Sun; Najia Li; Shujuan Jiang; Yiqiang Chen; Changzheng Wang; Lan Yang; Xiaoju Liu; Dong Yang; Wei Zhang; Zhuochang Chen; Qichang Lin; Chuntao Liu; Jianying Zhou; Xin Zhou; Chengping Hu; Ping Jiang; Wei Zhou; Jie Zhang; Shaoxi Cai; Chen Qiu; Mao Huang; Yijiang Huang; Huiguo Liu
Journal:  Allergy Asthma Immunol Res       Date:  2022-01       Impact factor: 5.764

4.  Associations between comorbidities and annual incidence plus frequency of asthma exacerbation hospitalisation during the past year: data from CARN study.

Authors:  Wenqiao Wang; Jiangtao Lin; Xin Zhou; Changzheng Wang; Mao Huang; Shaoxi Cai; Ping Chen; Qichang Lin; Jianying Zhou; Yuhai Gu; Yadong Yuan; Dejun Sun; Xiaohong Yang; Lan Yang; Jianmin Huo; Zhuochang Chen; Ping Jiang; Jie Zhang; Xianwei Ye; Huiguo Liu; Huaping Tang; Rongyu Liu; Chuntao Liu; Wei Zhang; Chengping Hu; Yiqiang Chen; Xiaoju Liu; Luming Dai; Wei Zhou; Yijiang Huang; Jianying Xu
Journal:  BMC Pulm Med       Date:  2022-07-01       Impact factor: 3.320

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.